The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.
Subscribe to H|T using this form to ensure you don’t miss out on the most important healthtech news every week!
For Montréal-based Clinia, which has spent the past few years ensuring its artificial intelligence-powered health-search infrastructure is “enterprise-grade,” the $10 million deal gives the healthtech startup fresh capital from Telus Ventures, a new customer in Telus Health, and a strong distribution network.
In an interview with BetaKit, Clinia co-founder and CEO Simon Bédard said that Telus’ approval grants the company’s tech the endorsement it needs to gain the trust of other large healthcare organizations in the United States (US)—and a better avenue for selling to them.
POWERED BY: CABHI
CABHI’s Mentorship, Capital, and Continuation (MC²) Program, in partnership with National Bank, is now accepting applications from early-stage Canadian companies looking to grow and scale their business. MC² is a first-of-its-kind investment program dedicated to supporting healthtech and fintech companies. This round of funding offers up to $500,000 in investment and acceleration services from CABHI.
Plus, eligible companies may access additional investment up to $250,000 from Invest Nova Scotia, $150,000 from Greyhill Capital Partners, commercialization and funding support from Ontario Bioscience Innovation Organization, and business financing from Clearco.
Apply now! The application deadline is January 22, 2024 at 5pm Eastern.
A Toronto maker of portable intensive-care units has signed one of the biggest contracts in years between a small Canadian supplier and the US Department of Defense.
Thornhill will provide up to $356-million USD of its portable, lightweight MADM anesthetic systems and MOVES SLC life-support-system equipment to the US military.
It is one of the biggest US defence contracts for a Canadian SME or woman-led business in at least the past decade, said Susannah Denovan Fortier, a spokeswoman for Canadian Commercial Corp.
Toronto-based artificial intelligence and biomedical startup BenchSci has reduced its headcount as the startup looks to adapt to the impact of generative AI in the field of drug discovery.
BenchSci cited several reasons behind its workforce reduction, including “shifts in the economic environment, operational efficiencies, and adaptation to technological advancements,” specifically citing generative AI.
“We believe that generative AI will continue to reshape preclinical [research and development] and have a substantial positive impact on our customers,” BenchSci said in its LinkedIn post.
Demis Hassabis, who co-founded Google’s AI unit and also leads the drugs offshoot Isomorphic Labs, told the Financial Times that its goal was to reduce the discovery stage — when potential drugs are identified before clinical trials — from the average of five years to two. “I think that would be success for us and be very meaningful,” he said.
Hassabis stated the goal days after announcing Isomorphic Lab’s first two pharmaceutical partnerships with Eli Lilly and Novartis, which came to a combined value of up to $3bn, in deals set to transform the finances of the unprofitable group.
Early-stage investing is fraught with steep risks and a long, uncertain path to returns, but those facts shouldn’t necessarily deter new entrants, according to Danielle Gifford, former executive director at Movement51.
“What people don’t realize is that early-stage investing is very much a viable asset class,” Gifford said in a sit-down interview with BetaKit at SAAS NORTH 2023.
Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.
It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold.
CES 2024: Mark Cuban, Glen Tullman sound off on building new models of care for consumers and AI’s impact
Amid all this hype, entrepreneur and investor Mark Cuban believes AI will be transformative for healthcare.
“There are two types of companies in the world — those who are great at AI and everyone else and either you know how to use it to your advantage or you’re in trouble,” he said during a digital health panel at CES on Thursday.
The influence of AI in our day-to-day activities is becoming more apparent. For Solon Angel, founder of MindBridge, we’re living in “a bit of an Internet moment.”
When it comes to industries with existing infrastructure, standards, and regulations, businesses can, as Angel puts it, “do a bit of judo.” This means using the weight of the opponent to your advantage, and focus on a very narrow entry point to improve existing processes.
Connecticut-based suicide prevention telehealth platform Vita Health has secured $22.5 million in Series A funding.
Vita Health connects telehealth providers with youth and adults contemplating suicide. The platform also provides teletherapy and psychiatry services for individuals with behavioral health conditions.
The funding will support the mental health company’s expansion.
Amazon’s “Just Walk Out” technology is coming to a hospital setting.
The retail giant announced the launch of “badge pay,” which will bring its payment technology that allows skipping the cashier line, to employee badges.
The badge is linked to the employee’s payroll deduct account, allowing them to pay for food and drinks around the clock, even after the hospital’s cafeteria is closed.